- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The statement includes the company’s comment on the recently completed Section 232 investigation into uranium imports by the US Department of Commerce.
Uranium company Laramide Resources (TSX:LAM,ASX:LAM) has released an announcement regarding the recent appointment Raffi Babikian to its board of directors. The statement also includes the company’s comment on the recently completed Section 232 investigation into uranium imports by the US Department of Commerce.
As quoted from the press release:
Laramide President and CEO Marc Henderson stated, ” “It is a potentially very opportune time for shareholders in uranium companies as years of under investment in potential future supply have created an unsustainable supply /demand balance that is likely to be resolved by higher uranium prices, regulatory action, or both.” In this regard, Laramide notes the completion last week of the US Department of Commerce’s (DOC) investigation into the national security implications of reliance on imported uranium. This “Section 232” investigation resulted in a confidential report and set of recommendations which have been forwarded by DOC to the White House. The President now has 90 days to decide whether to take action on the matter, a timeline which concludes on July 14, 2019.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.